Experts allay fears on JN.1 Covid variant in India

-

India announced 21 cases of the JN.1 Covid variant on Wednesday. Scientists allayed concerns but also advised adherence to current cautious measures, saying that the development is neither unexpected nor especially concerning.

The Union Health Ministry reported 614 new cases of Covid, the largest number of cases per day since May 21. This news coincided with the release of the new sub-variant’s increasing prevalence, which was found in three states.

Experts intervened as fear increased and Covid once again gained attention, assuring people that there was no reason to worry because there are effective therapies available, the infection is not severe, and viruses always evolve.

“As it happens with most respiratory viruses, including the influenza viruses, the circulating viruses keep changing. Therefore, a sub-variant of SARS CoV-2 is not a surprise at all,” Chandrakant Lahariya, a senior consultant physician and public health expert, was quoted as saying by news agency PTI.

According to him, the SARS-CoV-2 virus is spreading everywhere.

Official sources state that one case each in Kerala and Maharashtra and nineteen cases in Goa have been linked to JN.1. 16 COVID-19-related deaths in the last two weeks have been reported, and the victims had significant co-morbidities.

As of Tuesday, JN.1 is considered a distinct variation of interest (VOI) from parent lineage BA.2.86 by the World Health Organisation (WHO). It was formerly included in the BA.2.86 sublineages and designated as VOI.

A variation that possesses genetic alterations that may enhance its transmissibility, pathogenicity, and capacity to elude vaccinations is considered of interest by the World Health Organisation.

A variation of interest, according to the WHO, is one that includes genetic alterations that may boost its virulence, transmissibility, and its ability to evade vaccines.

“Despite this, with the onset of winter in the Northern Hemisphere, JN.1 could increase the burden of respiratory infections in many countries,” it added.

Additionally, India has warned the states to adopt the appropriate safety precautions.

(With agency inputs)



from Firstpost India Latest News https://ift.tt/5wonyU8
Ajeyo Basu

Comments

Post a Comment

Popular posts from this blog

Both COVID-19 vaccine doses needed for good protection against B16172 variant

-
It’s been a concerning few weeks in the UK, with the B16172 variant first taking hold and then spreading to become dominant. This more infectious form of the virus, initially identified in India, is what we’re now going to have to live with – unless it is out-competed by another variant in the future. Worryingly, experts had predicted that B16172 might be able to escape some of the effects of vaccines, which if true would threaten to derail the UK’s plans to finish lifting restrictions from the end of June. However, Public Health England (PHE) has looked at the ability of various variants to evade immunity and says that the UK’s vaccines remain effective against the variants circulating, including B16172. On the surface, this looks like good news. But delve a bit deeper, and things get more complicated, says Paul Hunter, professor of medicine at the University of East Anglia. PHE’s research found a little drop-off in protection against B16172 among people who were fully vaccinated.
Read more

New coronavirus variant emerge in India: How should our COVID response change?

-
Image
After genome sequencing of over 10,000 COVID-19 cases in India, researchers have discovered a new variant with two new mutations which may be better at evading the immune system. In 15-20 percent of samples from the Indian state of Maharashtra (the state accounting for 62 percent of cases in the country) a new, double mutation in key areas of the virus has been detected. These are now known as the E484Q and L452R mutations. What makes the variant different? Both these mutations are concerning because they are located in a key portion of the virus – the spike protein – that it uses to penetrate human cells. Spike proteins attach via a “receptor binding domain”, meaning the virus can attach to receptors in our cells. These new mutations include changes to the spike protein that make it a “better fit” for human cells. This means the virus can gain entry more easily and multiply faster. Given what we have seen with other similar mutations , it might also make it harder for our immu
Read more

120 flights delayed, 30 trains running late; Delhi fog & cold wave continue to give shiver to travellers

-
Arrival and departure of 120 flights, both domestic and international, to Delhi airport were affected due to dense fog and cold wave conditions on Wednesday, according to Delhi Airport FIDS (Flight Information Display System). As per the Delhi Airport FIDS, a total of 53 flights, including 21 domestic arrivals, 16 domestic departures, 13 international departures and three international arrivals scheduled are cancelled and not operating due to fog and other operational reasons from and to Indira Gandhi International (IGI) Airport in the national capital on 17 January. #WATCH | Delhi: Several flight operations delayed at IGI airport due to low visibility amid fog. pic.twitter.com/hG1DUKllEt — ANI (@ANI) January 17, 2024 Visuals from the Delhi airport showed passengers waiting outside, checking update of their scheduled flights. There were also some people waiting for flight of their families, friends and loved ones to arrive, which got delayed due to fog. #WATCH | Delhi | Pas
Read more